Skip to content
Clinical Trials – home

Gadoteric Acid: A Comprehensive Guide for Patients

8 / 15
trials open to patients / all trials
13+
Countries

In short

Gadoteric acid, also known as Dotarem, is a gadolinium-based contrast agent used in magnetic resonance imaging (MRI) to enhance image quality and improve diagnostic accuracy. This article explores various clinical trials investigating the use of gadoteric acid in different medical conditions and patient populations, including its safety profile and effectiveness in enhancing MRI scans.

At a glance

Primary Uses
MRI contrast agent for enhancing image quality in various body structures
Patient Populations Studied
Adults, children under 2 years, patients with mild to moderate renal insufficiency
Conditions Investigated
Inner ear and brain imaging, non-coronary MR angiography, heart failure with preserved ejection fraction
Safety Assessments
Monitoring of adverse events, changes in vital signs, ECG, and biomarkers
Comparative Studies
Comparison with other contrast agents (e.g., gadodiamide) for safety and efficacy
Long-term Follow-up
Some studies include follow-up periods of up to 24 months
Special Considerations
Caution in patients with severe renal dysfunction (GFR <30)

What is Gadoteric Acid?

Gadoteric acid, also known by its brand names Dotarem or Gd-DOTA, is a type of medication used in medical imaging. It belongs to a class of drugs called gadolinium-based contrast agents (GBCAs). These agents are used to enhance the quality of magnetic resonance imaging (MRI) scans, making certain structures in the body more visible to doctors.

Uses of Gadoteric Acid

Gadoteric acid is primarily used in the following situations:

  • Non-coronary MR angiography: This is a type of imaging used to examine blood vessels outside of the heart. It can help diagnose conditions like arterial occlusive disease, which is a narrowing or blockage of arteries.
  • Brain and inner ear imaging: Gadoteric acid can help visualize structures in the brain and inner ear, which is useful in diagnosing conditions like Meniere's disease, a disorder of the inner ear that can cause vertigo and hearing loss.
  • General MRI enhancement: It's used to improve the visibility of various structures throughout the body during MRI scans.

How Gadoteric Acid Works

Gadoteric acid works by altering the magnetic properties of water molecules in the body. When a patient undergoes an MRI after receiving gadoteric acid, the contrast agent causes certain areas to appear brighter or darker on the resulting images. This enhanced contrast helps doctors better visualize and distinguish between different types of tissues and structures in the body.

Safety and Side Effects

While gadoteric acid is generally considered safe, like all medications, it can cause side effects in some patients. Common side effects may include:

  • Headache
  • Nausea
  • Dizziness
  • Injection site reactions (such as pain or coldness)
  • Feeling of warmth

In rare cases, more serious allergic reactions can occur. These may include symptoms like hives, difficulty breathing, or swelling of the face, lips, tongue, or throat.

Special Considerations

Patients with kidney problems require special consideration when using gadoteric acid. This is because the kidneys are responsible for eliminating the contrast agent from the body. In people with severely impaired kidney function, there is a rare but serious risk of developing a condition called nephrogenic systemic fibrosis (NSF), which causes thickening and hardening of the skin and internal organs.

It's important to note that gadoteric acid is considered a macrocyclic GBCA, which is thought to be more stable and potentially safer than linear GBCAs, especially in patients with kidney problems.

Ongoing Research

Researchers continue to study gadoteric acid to better understand its safety profile and potential uses. Some areas of ongoing research include:

  • Use in children under 2 years of age: Studies are being conducted to assess the safety and effectiveness of gadoteric acid in very young children.
  • Comparison with other contrast agents: Researchers are comparing gadoteric acid with other types of contrast agents to determine their relative safety and effectiveness, particularly in patients with kidney problems.
  • Use in specific conditions: Studies are exploring the use of gadoteric acid in imaging specific conditions, such as osteoarthritis of the knee.

As with any medical procedure or medication, it's important to discuss the use of gadoteric acid with your healthcare provider. They can provide personalized advice based on your specific health situation and the reason for your MRI scan.

Questions people often ask

Conditions where Gadoteric Acid is being studied

Each condition opens its own overview and trial list

Trials with Gadoteric Acid

Recruiting trials first

See all 15 →
Quick filters
  • Participants:Adults · Healthy volunteers
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).